These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy. van de Putte EEF; Vegt E; Mertens LS; Bruining A; Hendricksen K; van der Heijden MS; Horenblas S; van Rhijn BWG Int Urol Nephrol; 2017 Sep; 49(9):1585-1591. PubMed ID: 28674853 [TBL] [Abstract][Full Text] [Related]
5. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817 [TBL] [Abstract][Full Text] [Related]
6. Pelvic Lymph Node Staging by Combined Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364 [TBL] [Abstract][Full Text] [Related]
7. Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy. Marandino L; Capozza A; Bandini M; Raggi D; Farè E; Pederzoli F; Gallina A; Capitanio U; Bianchi M; Gandaglia G; Fossati N; Colecchia M; Giannatempo P; Serafini G; Padovano B; Salonia A; Briganti A; Montorsi F; Alessi A; Necchi A Eur Urol Focus; 2021 Sep; 7(5):1092-1099. PubMed ID: 33172772 [TBL] [Abstract][Full Text] [Related]
8. Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients. Longoni M; Scilipoti P; Re C; Rosiello G; Nocera L; Pellegrino F; Basile G; de Angelis M; Quarta L; Burgio G; Necchi A; Cigliola A; Chiti A; Picchio M; Salonia A; Briganti A; Montorsi F; Moschini M BJU Int; 2024 Oct; 134(4):636-643. PubMed ID: 38621771 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037 [TBL] [Abstract][Full Text] [Related]
11. The role of 18F-FDG PET/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer. Moussa M; Chakra MA; Saad W; Dellis A; Papatsoris A Urol Oncol; 2021 Dec; 39(12):833.e9-833.e17. PubMed ID: 34059435 [TBL] [Abstract][Full Text] [Related]
12. Added Clinical Value of van Ginkel N; van Gennep EJ; Oosterbaan L; Greidanus J; Boellaard TN; Wondergem M; Vis AN; de Reijke TM; van Rhijn BWG; Mertens LS Clin Genitourin Cancer; 2023 Jun; 21(3):342-348. PubMed ID: 36918302 [TBL] [Abstract][Full Text] [Related]
13. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. Rouanne M; Girma A; Neuzillet Y; Vilain D; Radulescu C; Letang N; Yonneau L; Hervé JM; Botto H; Le Stanc E; Lebret T Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381 [TBL] [Abstract][Full Text] [Related]
14. Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. Goodfellow H; Viney Z; Hughes P; Rankin S; Rottenberg G; Hughes S; Evison F; Dasgupta P; O'Brien T; Khan MS BJU Int; 2014 Sep; 114(3):389-95. PubMed ID: 24341486 [TBL] [Abstract][Full Text] [Related]
15. Utility of Routine Preoperative Dason S; Wong NC; Donahue TF; Meier A; Zheng J; Mannelli L; Di Paolo PL; Dean LW; McPherson VA; Rosenberg JE; Bajorin DF; Capeanu M; Dalbagni G; Vargas HA; Bochner BH J Urol; 2020 Aug; 204(2):254-259. PubMed ID: 32134343 [TBL] [Abstract][Full Text] [Related]
16. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy. Fitoussi O; Roche JB; Riviere J; Wallerand H; Poulain JE; Gordien P; Galland S; Henriques B; Dupin C; Vincent M; Kuratle T; Saffarini M; Ramos-Pascual S Urol Int; 2023; 107(3):239-245. PubMed ID: 36657430 [TBL] [Abstract][Full Text] [Related]
18. FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Jeong IG; Hong S; You D; Hong JH; Ahn H; Kim CS Ann Surg Oncol; 2015 Sep; 22(9):3150-6. PubMed ID: 25634779 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic ability of Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]